We’ve been hearing about a hybrid model of clinical trials for a long time. This year, in the wake of the global pandemic that upended business as usual, these efforts are finally gaining traction.
The good news is that vendors will soon be beating a path to your virtual door with “hybrid-ready” EDC offerings. The bad news? You’ll have to wade through smoke and mirrors to figure out which solutions are actually a good fit for your needs.
This white paper can help. With an eye on the big picture (patient recruitment and retention), it guides you through using 3 key filters to evaluate your EDC options:
